Keyword Search
 
2016 | 2015 | 2014 | 2013 | 2012
DateTitle 
09/12/16Geron Provides Update on Imetelstat Trials Being Conducted by JanssenPrinter Friendly Version
09/11/16Geron Announces Conference Call on September 12 at 8:00 A.M. Eastern TimePrinter Friendly Version
08/03/16Geron Corporation Reports Second Quarter 2016 Financial Results and Recent EventsPrinter Friendly Version
07/27/16Geron Announces Conference Call to Discuss Second Quarter 2016 Financial ResultsPrinter Friendly Version
07/13/16Geron Announces Issuance of U.S. Patents Related to ImetelstatPrinter Friendly Version
05/05/16Geron Corporation Reports First Quarter 2016 Financial Results and Recent EventsPrinter Friendly Version
04/27/16Geron Announces Conference Call to Discuss First Quarter 2016 Financial ResultsPrinter Friendly Version
04/20/16Geron Announces Two Imetelstat Poster Presentations at the American Association for Cancer Research Annual MeetingPrinter Friendly Version
04/05/16Geron to Present at the Needham Healthcare ConferencePrinter Friendly Version
03/17/16Geron Announces Presentations at American Association of Cancer Research Annual MeetingPrinter Friendly Version
02/25/16Geron Corporation Reports Fourth Quarter and Annual 2015 Financial ResultsPrinter Friendly Version
02/17/16Geron Announces Conference Call to Discuss Fourth Quarter and Annual 2015 Financial ResultsPrinter Friendly Version
02/10/16Geron to Present at the RBC Capital Markets Healthcare ConferencePrinter Friendly Version
01/14/16Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic SyndromesPrinter Friendly Version


RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | Financial Tear Sheet Financial Tear Sheet
Close
Form content here please :)